ABVC BioPharma Inc.

ABVC | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.14

-$0.01 (-0.87%)

Sep 22, 2026, 2:42 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $29.9M

Enterprise Value $31.57M

Beta 0.54

Average Volume 129.14K

Shares Outstanding (Diluted) 26.06M

Shares Change YoY 49.88%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US00091F3047

Price Performance

Price Change 1M 29.2%

Price Change 3M -12.2%

Price Change 6M 6.5%

Price Change YTD -47.5%

Price Change 1Y -59.9%

Price Change 3Y 30.7%

Price Change 5Y -95.4%

1M CAGR (ann.) 12.8%

1Y CAGR (ann.) -57.7%

5Y CAGR (ann.) -47.9%

All-Time CAGR -50.0%

Valuation

PE Ratio -3.97

Forward PE 1.65

PEG Ratio 0.06

Forward PEG 0.03

PS Ratio -37.57

Forward PS N/A

PB Ratio 2.91

P/FCF Ratio -12.22

P/Adj. FCF Ratio -5.19

P/OCF Ratio -11.50

EV/Sales -39.66

EV/EBIT -3.83

EV/EBITDA -4.03

EV/FCF -12.90

Earnings Yield -25.2%

FCF Yield -8.2%

Adj. FCF Yield -19.3%

Financial Health

Net Cash $94.36K

Total Debt $1.76M

Cash & Short-Term Investments $94.36K

Total Assets $19.4M

Current Ratio 0.07

Quick Ratio 0.07

Debt / Equity Ratio 0.17

Debt / EBITDA -0.23

Debt / FCF -0.72

OCF / Debt -1.53

Interest Coverage -47.11

Altman Z-Score -4.97

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 100.0%

Operating Profit Margin 918.5%

EBITDA Margin 983.2%

Net Profit Margin 992.9%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue -415.8%

SBC Impact (per share) -135.3%

Returns

Return on Assets -40.7%

Return on Equity -71.5%

Return on Invested Capital -52.0%

Return on Capital Employed -53.3%

Return on Tangible Assets -40.7%

Historical Growth (CAGR)

Revenue CAGR 3Y -521.2%

Revenue CAGR 5Y -154.2%

Revenue CAGR 10Y -13.7%

EPS CAGR 3Y 95.3%

EPS CAGR 5Y 64.0%

EPS CAGR 10Y 10.6%

FCF CAGR 3Y 11.1%

FCF CAGR 5Y 42.2%

FCF CAGR 10Y -5.5%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Nov 15, 2026

EPS Estimate (next Q) -$0.40

EPS Growth Est (next Q) 700.0%

Revenue Est (next Q) $113.26K

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-2.69M

Free Cash Flow $-2.45M

Adj. Free Cash Flow $-5.76M

FCF Per Share -$0.09

OCF Per Share -$0.10

OCF/S Ratio 338.1%

Income Statement

Revenue $-795.95K

Gross Profit $-795.95K

Operating Income $-7.31M

EBITDA $-7.83M

Net Income $-7.9M

EPS (Diluted) -$0.29

Revenue / Employee $-44.22K

Profit / Employee $-439.03K

Employees 18